Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
August 08, 2023
Global Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others) – Industry Trends and Forecast to 2029.
There is a huge rise in the number of diseases and disorders owing to the viral and bacterial infection. To study the live viruses and monitor the tissue health, a rising number of scientists and researchers are inducing their resources to revolutionize the drug delivery systems. The drug delivery devices are easily available via both online and offline modes of distribution but can be availed only with a prescription.
From the name itself, it is clear that drug delivery devices are the medical devices that are used to deliver the drugs in the body of patients with an aim to immune the body against infections and disease cells in the body. The drug delivery devices are used for numerous medical treatments and provide a therapeutic relief to the patients.
| REPORT METRIC | DETAILS |
| Forecast Period | 2022 to 2029 |
| Base Year | 2021 |
| Historic Years | 2020 (Customizable to 2019 - 2014) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
| Segments Covered | Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others) |
| Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
| Market Players Covered | BD (US); F. Hoffmann-La Roche Ltd (Switzerland); Antares Pharma (US); Novartis AG (Switzerland); 3M (US); Sulzer Ltd (Switzerland); Gerresheimer AG (Germany); Sanofi (France); Johnson & Johnson Services, Inc. (US); Bayer AG (Germany); GlaxoSmithKline plc (UK); Novosanis (Belgium); MEDMIX SYSTEMS AG (Switzerland); Merck & Co., Inc. (Germany); Pfizer Inc. (US); Insulet Corporation (US); OraSure Technologies, Inc. (US); Enable Injections (US); West Pharmaceutical Services, Inc. (US); SMC Ltd. (Philippines); ViVO Smart Medical Devices Ltd. (UK) and Cipla Inc. (US) |
Surging prevalence of acute and chronic diseases and infections all around the globe is one of the major factors responsible for fostering growth in the market value. According to a recent report, there are more than 20 million in the country suffering from diabetes and this number is projected to surpass 57 million by 2025.
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted over live viruses with an aim to develop drugs is also bolstering the market growth rate.
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Moreover, growing initiatives by the government to provide the best of drugs against cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases and others in the remote areas will further carve the way for the growth.
Additionally, surge in the personal disposable income level, introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices and rising number of cancers, respiratory diseases, and diabetic patients in the backward economies, positively affect the market growth rate.
Furthermore, upsurge in the public-private funding for target research activities, increasing levels of air pollution, and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and imposition of stringent regulations on drug delivery systems are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This drug delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 has had a positive impact on the market. This is because of the increasing focus of the pharmaceutical companies towards offering efficient medical treatment to the COVID-19 patients. Moreover, the discovery of vaccine led to the global rise in its demand which in turn created a huge scope of growth for the market. Strategic collaborations among the major players for the development of effective drugs further propelled the market growth.
The drug delivery devices market is segmented on the basis of route of administration, patient care setting and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Based on route of administration, the drug delivery devices market is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery.
Based on patient care setting, the drug delivery devices market is segmented into hospitals, diagnostic centers, ambulatory surgery centers or clinics, home care settings and others.
Based on application, the drug delivery devices market is segmented into cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders and others.
The drug delivery devices market is analysed and market size insights and trends are provided by country, route of administration, patient care setting and application as referenced above.
The countries covered in the drug delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the drug delivery devices market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, growing number of processes pertaining to drug development, rising prevalence of chronic diseases, the presence of a large number of pharmaceutical companies and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, increasing incidences of chronic diseases for example cardiovascular diseases, diabetes, cancer and other diseases and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The drug delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug delivery devices market. The data is available for historic period 2010-2020.
The drug delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery devices market.
Some of the major players operating in the drug delivery devices market are BD. (US); F. Hoffmann-La Roche Ltd (Switzerland); Antares Pharma (US); Novartis AG (Switzerland); 3M (US); Sulzer Ltd (Switzerland); Gerresheimer AG (Germany); Sanofi (France); Johnson & Johnson Services, Inc. (US); Bayer AG (Germany); GlaxoSmithKline plc (UK); Novosanis (Belgium); MEDMIX SYSTEMS AG (Switzerland); Merck & Co., Inc. (Germany); Pfizer Inc. (US); Insulet Corporation (US); OraSure Technologies, Inc. (US); Enable Injections (US); West Pharmaceutical Services, Inc. (US); SMC Ltd. (Philippines); ViVO Smart Medical Devices Ltd. (UK) and Cipla Inc. (US) among others.
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis.
From https://www.databridgemarketresearch.com/reports/global-drug-delivery-devices-market
The above is the Global Drug Delivery Devices Market – Industry Trends and Forecast to 2029 we have listed for you. You can submit the following form to obtain more industry information we provide for you.
You can visit our website or contact us, and we will provide the latest consultation and solutions
Send Inquiry
lastest New
Related Products
Send Inquiry
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.